HGHRX
Price
$32.86
Change
-$0.40 (-1.20%)
Updated
May 9 closing price
Net Assets
805.5M
JFNIX
Price
$63.94
Change
-$0.88 (-1.36%)
Updated
May 9 closing price
Net Assets
4.66B
Ad is loading...

HGHRX vs JFNIX

Header iconHGHRX vs JFNIX Comparison
Open Charts HGHRX vs JFNIXBanner chart's image
Hartford Healthcare R3
Price$32.86
Change-$0.40 (-1.20%)
VolumeN/A
Net Assets805.5M
Janus Henderson Global Life Sciences I
Price$63.94
Change-$0.88 (-1.36%)
VolumeN/A
Net Assets4.66B
HGHRX vs JFNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HGHRX vs. JFNIX commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a Buy and JFNIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.66B vs. HGHRX (806M). JFNIX pays higher dividends than HGHRX: JFNIX (0.39) vs HGHRX (0.00). HGHRX was incepted earlier than JFNIX: HGHRX (18 years) vs JFNIX (16 years). HGHRX (1.63) is less costly to investors than JFNIX (0.77). HGHRX is a more actively managed with annual turnover of: 40.00 vs. JFNIX (35.00). HGHRX has a lower initial minimum investment than JFNIX: HGHRX (0) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -12.86 vs. HGHRX (-16.47). JFNIX return over 5 years is better than : 9.52 vs. HGHRX (-15.74).
HGHRXJFNIXHGHRX / JFNIX
Total Expense Ratio1.630.77212%
Annual Report Gross Expense Ratio1.630.77212%
Fund Existence18 years16 years-
Gain YTD-7.280-5.998121%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets806M4.66B17%
Annual Yield % from dividends0.000.39-
Returns for 1 year-16.47-12.86128%
Returns for 3 years-2.0610.45-20%
Returns for 5 years-15.749.52-165%
Returns for 10 years-18.8610.24-184%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSGCX21.530.07
+0.33%
Virtus KAR Small-Cap Growth C
PSLCX9.890.03
+0.30%
Putnam Small Cap Value C
GSATX29.860.05
+0.17%
Goldman Sachs Small Cp Val Insghts A
AKREX67.95-0.34
-0.50%
Akre Focus Retail
LOGSX20.00-0.15
-0.74%
Live Oak Health Sciences